EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical outcomes with oral cephalosporins as definitive treatment of Enterobacterales bacteremia from a urinary source based on cefazolin minimum inhibitory concentration

Lauren Kobasuk iD, Tamara Cisowska iD, Karen Howard, Christian Gabriel, Chaorong Wu, Hannah Imlay, Emily S Spivak, Kara Nazminia iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01357-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Lauren Kobasuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Utah Health, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Cefazolin, Anti-Bacterial Agents, Bacteremia, Cephalosporins. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cefazolin breakpoints differ for the treatment of Enterobacterales urinary tract infections and systemic infections. A retrospective, exploratory cohort study of 148 patients found no difference in 30-day treatment outcomes based on the blood culture cefazolin minimum inhibitory concentration (≤2 mcg/mL versus 4–16 mcg/mL) for patients transitioned to PO cephalosporins for the treatment of Escherichia coli , Klebsiella pneumoniae , or Proteus mirabilis bacteremia secondary to a urinary source. Further research should confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefazolinAnti-Bacterial AgentsBacteremiaCephalosporinsUrinary Tract InfectionsEnterobacteriaceae InfectionsHumansMicrobial Sensitivity TestsProteus mirabilisRetrospective StudiesKlebsiella pneumoniaeEscherichia coliFirst Generation CephalosporinsThird Generation CephalosporinsTreatment OutcomeAdministration, OralEnterobacteriaceae

Stichwörter der Autor:innen

Enterobacterales bacteremiacephalosporins

Substanzen

CefazolinAnti-Bacterial AgentsCephalosporinsFirst Generation CephalosporinsThird Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Pharmacy, University of Utah Health, Salt Lake City, Utah, USA.
  • Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.

ORCID-Profile: Lauren Kobasuk, Tamara Cisowska, Kara Nazminia

Zitieren

APA

Kobasuk, L., Cisowska, T., Howard, K., Gabriel, C., Wu, C., Imlay, H., Spivak, E. S., & Nazminia, K. (2026). Clinical outcomes with oral cephalosporins as definitive treatment of Enterobacterales bacteremia from a urinary source based on cefazolin minimum inhibitory concentration. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01357-25

Vancouver

Kobasuk L, Cisowska T, Howard K, Gabriel C, Wu C, Imlay H, et al. Clinical outcomes with oral cephalosporins as definitive treatment of Enterobacterales bacteremia from a urinary source based on cefazolin minimum inhibitory concentration. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01357-25

BibTeX
@article{Kobasuk2026,
  author = {Kobasuk, Lauren and Cisowska, Tamara and Howard, Karen and Gabriel, Christian and Wu, Chaorong and Imlay, Hannah and Spivak, Emily S and Nazminia, Kara},
  title = {Clinical outcomes with oral cephalosporins as definitive treatment of Enterobacterales bacteremia from a urinary source based on cefazolin minimum inhibitory concentration},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01357-25}
}
Kostenlos starten →